Calcipotriene and Betamethasone Topical Suspension
Generic name: calcipotriene and betamethasone dipropionate
Dosage form: topical suspension
Drug class:Topical antipsoriatics
Medically reviewed by Drugs.com. Last updated on Oct 1, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Use In Specific Populations
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Calcipotriene and Betamethasone Topical Suspension
Calcipotriene and Betamethasone Dipropionate Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp in patients 12 years and older and plaque psoriasis of the scalp and body in patients 18 years and older.
Additional pediatric use information is approved for LEO Pharma A/S’s Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension. However, due to Leo Pharma A/S’s marketing exclusivity rights, this drug product is not labeled with that information.
Calcipotriene and Betamethasone Topical Suspension Dosage and Administration
Instruct patients to shake bottle prior to using Calcipotriene and Betamethasone Dipropionate Topical Suspension. Apply Calcipotriene and Betamethasone Dipropionate Topical Suspension to affected areas on the scalp and body once daily for up to 8 weeks. Calcipotriene and Betamethasone Dipropionate Topical Suspension should be discontinued when control is achieved. Instruct patients to wash their hands after applying the product. Inform patients that they should not take a bath or shower or wash their hair right after application of Calcipotriene and Betamethasone Dipropionate Topical Suspension.
Patients 12 to 17 years should not use more than 60 grams per seek and patients 18 years and older should not use more than 100 grams per week.
Calcipotriene and Betamethasone Dipropionate Topical Suspension should not be:
- •
- Used with occlusive dressings unless directed by a healthcare provider.
- •
- Used on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
- •
- Applied to the scalp in the 12 hours before or after any chemical treatments to the hair.
Calcipotriene and Betamethasone Dipropionate Topical Suspension is not for oral, ophthalmic, or intravagina...